DIN 02245565 — XATRAL 10 MG
XATRAL is a tablet (extended-release) of Alfuzosin marketed by SANOFI-AVENTIS CANADA INC. The full Alfuzosin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02245565
- Brand name
- XATRAL
- Active ingredient
- Alfuzosin
- Strength
- 10 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- SANOFI-AVENTIS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Alpha1-adrenergic receptor antagonist (alpha-blocker)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Alfuzosin products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02447576 | ALFUZOSIN | 10 MG | TABLET (EXTENDED-RELEASE) | SIVEM PHARMACEUTICALS ULC | MARKETED |
| 02519844 | ALFUZOSIN | 10 MG | TABLET (EXTENDED-RELEASE) | SANIS HEALTH INC | MARKETED |
| 02315866 | APO-ALFUZOSIN | 10 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02443201 | AURO-ALFUZOSIN | 10 MG | TABLET (EXTENDED-RELEASE) | AURO PHARMA INC | MARKETED |
| 02304678 | SANDOZ ALFUZOSIN | 10 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |